DOCSLIB.ORG

Synthesis of Novel Azetidines

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Synthesis of Novel Azetidines University of New Orleans ScholarWorks@UNO University of New Orleans Theses and Dissertations Dissertations and Theses Fall 12-20-2013 Synthesis of Novel Azetidines Amber Thaxton UNO, [email protected] Follow this and additional works at: https://scholarworks.uno.edu/td Part of the Medicinal and Pharmaceutical Chemistry Commons, and the Organic Chemistry Commons Recommended Citation Thaxton, Amber, "Synthesis of Novel Azetidines" (2013). University of New Orleans Theses and Dissertations. 1764. https://scholarworks.uno.edu/td/1764 This Dissertation is protected by copyright and/or related rights. It has been brought to you by ScholarWorks@UNO with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in University of New Orleans Theses and Dissertations by an authorized administrator of ScholarWorks@UNO. For more information, please contact [email protected]. Synthesis of Novel Azetidines A Dissertation Submitted to the Graduate Faculty of the University of New Orleans in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry by Amber Nichole Thaxton B.S. Clemson University, 2004 M.S. University of New Orleans, 2013 December 2013 For my family: To my mom, Bee Thaxton, for everything she has done for me. I am extremely thankful for her constant support and reassurance. To Teddy for his ability to make me smile especially when I am stressed. To Robby who has my heart. ii Acknowledgement I would like to express my extreme gratitude to my adviser Dr. Mark Trudell for taking a chance on me, and for providing his support and guidance throughout my classes and research. I would like to also thank my advisory board members Dr. Branko Jursic, Dr. Edwin Stevens, and Dr. Dhruva Chakravorty. I would like to acknowledge Dr. Edwin Stevens for the X-ray crystal structure, as well as Dr. David Mobley and Vivan Jaber for the structure overlay. I would also like to thank Dr. Sari Izenwasser and Mr. Dean Wade of the University of Miami Miller School of Medicine for their collaborative efforts in producing biological analysis for this dissertation. I wish to express my appreciation to my group members past and present for their encouragement and support: Dr. April Noble-Brooks, Dr. Andréa “Tascha” Forsyth, Alex Sherwood, Kiran Thoa, Tushar Apsunde, Maria Lindsay, Patrick Apipanyakul, and Majeed Bajaber. The National Institute of Drug Abuse and the University of New Orleans Graduate School and College of Sciences are gratefully acknowledged for financial support of this work. iii Table of Contents List of Figures ....................................................................................................................................... vii List of Schemes .................................................................................................................................... viii List of Tables ............................................................................................................................................ x Abstract ..................................................................................................................................................... x Part I: Synthesis and Biological Evaluation of 3-aryl-3-arylmethoxy azetidines ........... 1 Abstract ....................................................................................................................................... 1 Introduction ............................................................................................................................... 3 1.1History of Methamphetamine ............................................................................. 3 1.2 Effects of Meth ......................................................................................................... 9 1.4 Effects of METH on Neurotransporters ...................................................... 12 1.5 Methamphetamine vs Cocaine ........................................................................ 15 1.6 Attempted Methamphetamine Medications.............................................. 16 1.7 Dual Target Hypothesis ..................................................................................... 18 1.8 Triple Re-uptake Inhibitors in Clinical Trials ........................................... 20 1.9 Ibudilast ................................................................................................................... 21 1.10 Approach and Investigation of 3-Aryl-3-arylmethoxytropanes ..... 22 1.11 Design Strategy for Novel 3-Aryl-3-arylmethoxyazetidines ............ 30 iv Results and Discussion ......................................................................................................... 34 2.1 Synthesis of 3-Aryl-3-arylmethoxyazetidine and N-Methyl-3-aryl- 3-arylmethoxyazetidine ....................................................................................... 34 2.1.1 Synthesis of N-Boc-3-aryl-3-azetidinol ................................................ 34 2.1.2 Synthesis of N-Boc-3-aryl-3-arylmethoxyazetidine ...................... 37 2.1.3 Optimization for Formation of N-Methyl Azetidine ........................ 42 2.1.4 Optimization of Formation of 3-Aryl-3-arylmethoxyazetidine .. 45 2.1.5 Forward Synthesis and Crystallographic Representation............ 51 2.2 Binding Affinity ................................................................................................. 53 2.3 Binding Affinities of 3-Aryl-3-arylmethoxyazetidine and N-Methyl- 3-aryl-3-arylmethoxy analogs ............................................................................ 54 Conclusion ................................................................................................................................ 59 Experimental Section ............................................................................................................ 61 Part II: Synthesis of 3,3-diaryl Azetidines .................................................................................. 95 Abstract ..................................................................................................................................... 95 Introduction ............................................................................................................................. 96 4.1 Pharmaceutical Examples of Diaryl Heterocycles ............................................. 97 4.2.1 Synthesis of 3,3-Diarylpyrrolidine from Benzophenone ............................ 98 4.2.2 Synthesis of 3,3-Diarylpyrrolidine from Diphenylbutylamine ................. 99 4.2.3 Synthesis of 3,3-Diarylpyrrolidine from Diphenylacetonitrile ............... 100 4.2.4 Synthesis of 4,4-Diarylpiperidines from 4-Piperidinone .......................... 101 v 4.3 New Methodology ........................................................................................................ 103 Results and Discussion ...................................................................................................... 106 5.1 Proposed Mechanism of Formation of 3,3-Diarylheterocycles .................. 106 5.2 Synthesis of Symmetrical and Asymmetrical 3,3-Diarylazetidines .......... 107 5.3 Synthesis of 4,4-Diarylpiperidine, 3,3-Diarylpyrrolidine, and 4,4- Diaryltropane ........................................................................................................................ 109 Conclusions ........................................................................................................................... 115 Experimental ........................................................................................................................ 116 References .......................................................................................................................................... 131 Appendix I ........................................................................................................................................... 144 Appendix II ......................................................................................................................................... 145 Vita ........................................................................................................................................................ 155 vi List of Figures FIGURE 1: TRANSPORTATION OF DOPAMINE AT A DOPAMINE TRANSPORTER SYNAPTIC CLEFT .................... 11 FIGURE 2: EFFECTS OF METH ON DOPAMINE TRANSPORTER .......................................................................... 12 FIGURE 3: PET SCAN EVALUATING DOPAMINE LEVELS OF A HEALTHY BRAIN AND A BRAIN OF A METH ABUSER ............................................................................................................................................................ 13 FIGURE 4: EFFECT OF COCAINE ON THE DOPAMINE TRANSPORTER SYSTEM .................................................... 15 FIGURE 5: APPROACH TO PHARMACOPHORE SCAFFOLD .................................................................................... 27 FIGURE 6: MODIFICATION AREAS FOR INCREASED BINDING AFFINITIES .......................................................... 30 FIGURE 7: SUPERIMPOSED PREDICTED
Load more

Recommended publications
  • Bromobenzene D5
    Safety data sheet according to Regulation (EC) No. 1907/2006 (REACH), amended by 2015/830/EU Bromobenzene D5 99,5 Atom%D article number: HN93 date of compilation: 2020-09-02 Version: 1.0 en SECTION 1: Identification of the substance/mixture and of the company/ undertaking 1.1 Product identifier Identification of the substance Bromobenzene D5 99,5 Atom%D Article number HN93 Registration number (REACH) It is not required to list the identified uses be- cause the substance is not subject to registration according to REACH (< 1 t/a) EC number 224-013-8 CAS number 4165-57-5 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses: laboratory chemical laboratory and analytical use 1.3 Details of the supplier of the safety data sheet Carl Roth GmbH + Co KG Schoemperlenstr. 3-5 D-76185 Karlsruhe Germany Telephone: +49 (0) 721 - 56 06 0 Telefax: +49 (0) 721 - 56 06 149 e-mail: [email protected] Website: www.carlroth.de Competent person responsible for the safety data : Department Health, Safety and Environment sheet: e-mail (competent person): [email protected] 1.4 Emergency telephone number Name Street Postal code/ Telephone Website city National Poisons Inform- Dudley Rd B187QH Birm- 844 892 0111 ation Service ingham City Hospital Emergency information service +49/(0)89 19240 SECTION 2: Hazards identification 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 (CLP) Classification acc. to GHS Section Hazard class Hazard class and cat- Hazard egory state- ment 2.6 flammable liquid (Flam.
    [Show full text]
  • Chem 353: Grignard
    GRIG.1 ORGANIC SYNTHESIS: BENZOIC ACID VIA A GRIGNARD REACTION TECHNIQUES REQUIRED : Reflux with addition apparatus, rotary evaporation OTHER DOCUMENTS Experimental procedure, product spectra INTRODUCTION In this experiment you will synthesise benzoic acid using bromobenzene to prepare a Grignard reagent, which is then reacted with carbon dioxide, worked-up and purified to give the acid. This sequence serves to illustrate some important concepts of practical synthetic organic chemistry : preparing and working with air and moisture sensitive reagents, the "work-up", extractions, apparatus set-up, etc. The synthesis utilises one of the most important type of reagents discussed in introductory organic chemistry, organometallic reagents. In this reaction, the Grignard reagent (an organomagnesium compound), phenylmagnesium bromide is prepared by reaction of bromobenzene with magnesium metal in diethyl ether (the solvent). The Grignard reagent will then be converted to benzoic acid via the reaction of the Grignard reagent with excess dry ice (solid CO2) followed by a "work-up" using dilute aqueous acid : The aryl (or alkyl) group of the Grignard reagent behaves as if it has the characteristics of a carbanion so it is a source of nucleophilic carbon. It is reasonable to represent the structure of the - + Grignard reagent as a partly ionic compound, R ....MgX. This partially-bonded carbanion is a very strong base and will react with acids (HA) to give an alkane: RH + MgAX RMgX + HA Any compound with suitably acidic hydrogens will readily donate a proton to destroy the reagent. Water, alcohols, terminal acetylenes, phenols and carboxylic acids are just some of the functional groups that are sufficiently acidic to bring about this reaction which is usually an unwanted side reaction that destroys the Grignard reagent.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,455,647 B2 Delong Et Al
    USOO8455647B2 (12) United States Patent (10) Patent No.: US 8,455,647 B2 deLong et al. (45) Date of Patent: *Jun. 4, 2013 (54) 6-AMINOISOQUINOLINE COMPOUNDS 7,671,205 B2 3/2010 deLong et al. 8,034,943 B2 10/2011 delong et al. 2004/0091946 A1 5/2004 Oakley et al. (75) Inventors: Mitchell A. deLong, Chapel Hill, NC 2005/OO32125 A1 2/2005 Oakley et al. (US); Jill Marie Sturdivant, Chapel 2005/0176712 A1 8/2005 Wakabayashi et al. Hill, NC (US); Geoffrey Richard 2005/0282805 A1 12/2005 Hangeland et al. Heintzelman, Durham, NC (US); Susan 2006/027O670 A1 11/2006 Chew et al. M. Royalty, Cary, NC (US) 2007/011 1983 A1 5/2007 Fong 2007/O123561 A1 5/2007 Lee et al. 2007/01294.04 A1 6/2007 Hagihara et al. (73) Assignee: Aerie Pharmaceuticals, Inc., Research 2007/O135499 A1 6/2007 deLong et al. Triangle Park, NC (US) 2007/0142429 A1 6/2007 deLong et al. 2007/O149473 A1 6/2007 Chatterton et al. (*) Notice: Subject to any disclaimer, the term of this 2007/014.9548 A1 6/2007 Hellberg et al. patent is extended or adjusted under 35 2007/0167444 A1 7/2007 Kuramochi et al. 2007/0173530 A1 7/2007 deLong et al. U.S.C. 154(b) by 0 days. 2007/0238741 A1 10/2007 Nagarathnam et al. 2008, 0021026 A1 1/2008 Kahraman et al. This patent is Subject to a terminal dis 2008, 0021217 A1 1/2008 Borchardt et al. claimer. 2008, OO58384 A1 3/2008 Lee et al.
    [Show full text]
  • TOXICOLOGICAL REVIEW of BROMOBENZENE (CAS No
    EPA/635/R-07/002F www.epa.gov/iris TOXICOLOGICAL REVIEW OF BROMOBENZENE (CAS No. 108-86-1) In Support of Summary Information on the Integrated Risk Information System (IRIS) September 2009 U.S. Environmental Protection Agency Washington, DC DISCLAIMER This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. ii CONTENTS−TOXICOLOGICAL REVIEW OF BROMOBENZENE (CAS No. 108-86-1) LIST OF TABLES......................................................................................................................... vi LIST OF FIGURES ....................................................................................................................... ix LIST OF ABBREVIATIONS AND ACRONYMS ....................................................................... x FOREWORD ................................................................................................................................. xi AUTHORS, CONTRIBUTORS, AND REVIEWERS ................................................................ xii 1. INTRODUCTION ..................................................................................................................... 1 2. CHEMICAL AND PHYSICAL INFORMATION RELEVANT TO ASSESSMENTS .......... 3 3. TOXICOKINETICS .................................................................................................................. 6 3.1. ABSORPTION ................................................................................................................
    [Show full text]
  • The Ozonolysis of Phenyl Grignard Reagent
    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 1971 The ozonolysis of phenyl Grignard reagent Gale Manning Sherrodd The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Sherrodd, Gale Manning, "The ozonolysis of phenyl Grignard reagent" (1971). Graduate Student Theses, Dissertations, & Professional Papers. 8297. https://scholarworks.umt.edu/etd/8297 This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. THE OZONOLYSIS OF PHENYL GRIGNARD REAGENT By Gale M. Sherrodd B.S., Rocky Mountain College, I969 Presented in partial fulfillment of the requirements for the degree of Master of Arts for Teachers UNIVERSITY OF MONTANA 1971 Approved by: Chairman, Board of Examiners De^ , Graduate *School / n ? / Date Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. UMI Number: EP39098 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. UMT DiMMtstion PuWiahing UMI EP39098 Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author.
    [Show full text]
  • TOXICOLOGICAL REVIEW of BROMOBENZENE (CAS No
    DRAFT - DO NOT CITE OR QUOTE EPA/635/R-07/002 www.epa.gov/iris TOXICOLOGICAL REVIEW OF BROMOBENZENE (CAS No. 108-86-1) In Support of Summary Information on the Integrated Risk Information System (IRIS) June 2007 NOTICE This document is an interagency review draft. It has not been formally released by the U.S. Environmental Protection Agency and should not at this stage be construed to represent Agency position on this chemical. It is being circulated for review of its technical accuracy and science policy implications. U.S. Environmental Protection Agency Washington, DC DISCLAIMER This document is a preliminary draft for review purposes only and does not constitute U.S. Environmental Protection Agency policy. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. 6/7/07 ii DRAFT – DO NOT CITE OR QUOTE CONTENTSCTOXICOLOGICAL REVIEW OF BROMOBENZENE (CAS No. 108-86-1) LIST OF FIGURES ....................................................................................................................... vi LIST OF TABLES........................................................................................................................ vii LIST OF ABBREVIATIONS AND ACRONYMS ........................................................................x FOREWORD ................................................................................................................................. xi AUTHORS, CONTRIBUTORS, AND REVIEWERS ................................................................ xii
    [Show full text]
  • Chlorobenzene
    CHLOROBENZENE What is CHLOROBENZENE? Chlorobenzene is a man-made colorless liquid that burns quickly. It has a pleasant smell like the smell of almonds. Some of it will dissolve in water. It also turns into a vapor and goes into the air. Chlorobenzene is not found in nature. Where can chlorobenzene be found and how is it used? Over the past 40 years in the United States, less cholorobenzene is being manufactured. In the past, cholorobenzene was used to make phenol and DDT. Today, it is still used to produce pesticides and chemicals used to prevent or kill unwanted pests. Chlorobenzene may be also be used to grease car parts. Chlorobenzene sent into the air is slowly broken down by other chemicals and sunlight. It can be removed from the air by rain. In water, chlorobenzene will quickly turn into a vapor, or be broken down by bacteria. When it enters soil, most of it is broken down quickly by bacteria and the rest will turn into a vapor or leach into groundwater. How can people be exposed to chlorobenzene? You could be exposed to chlorobenzene through: Breathing the chemical. People who work in places where chlorobenzene is processed or handled are at greatest risk. If you live near a waste site, you could be exposed to vapors in the air. Eating or drinking food or water that has been in contact with chlorobenzene. If you live near a waste site, you could be exposed from water contaminated by chlorobenzene. Touching soil contaminated with chlorobenzene. This happens to people who live near a waste site or a factory.
    [Show full text]
  • Reactions of Aromatic Compounds Just Like an Alkene, Benzene Has Clouds of  Electrons Above and Below Its Sigma Bond Framework
    Reactions of Aromatic Compounds Just like an alkene, benzene has clouds of electrons above and below its sigma bond framework. Although the electrons are in a stable aromatic system, they are still available for reaction with strong electrophiles. This generates a carbocation which is resonance stabilized (but not aromatic). This cation is called a sigma complex because the electrophile is joined to the benzene ring through a new sigma bond. The sigma complex (also called an arenium ion) is not aromatic since it contains an sp3 carbon (which disrupts the required loop of p orbitals). Ch17 Reactions of Aromatic Compounds (landscape).docx Page1 The loss of aromaticity required to form the sigma complex explains the highly endothermic nature of the first step. (That is why we require strong electrophiles for reaction). The sigma complex wishes to regain its aromaticity, and it may do so by either a reversal of the first step (i.e. regenerate the starting material) or by loss of the proton on the sp3 carbon (leading to a substitution product). When a reaction proceeds this way, it is electrophilic aromatic substitution. There are a wide variety of electrophiles that can be introduced into a benzene ring in this way, and so electrophilic aromatic substitution is a very important method for the synthesis of substituted aromatic compounds. Ch17 Reactions of Aromatic Compounds (landscape).docx Page2 Bromination of Benzene Bromination follows the same general mechanism for the electrophilic aromatic substitution (EAS). Bromine itself is not electrophilic enough to react with benzene. But the addition of a strong Lewis acid (electron pair acceptor), such as FeBr3, catalyses the reaction, and leads to the substitution product.
    [Show full text]
  • Ligand-Based Pharmacophore Studies in the Dopaminergic System Amar P
    University of Wollongong Research Online University of Wollongong Thesis Collection University of Wollongong Thesis Collections 2011 Ligand-based pharmacophore studies in the dopaminergic system Amar P. Inamdar University of Wollongong Recommended Citation Inamdar, Amar P., Ligand-based pharmacophore studies in the dopaminergic system, Doctor of Philosophy thesis, School of Chemistry, University of Wollongong, 2011. http://ro.uow.edu.au/theses/3535 Research Online is the open access institutional repository for the University of Wollongong. For further information contact Manager Repository Services: [email protected]. LIGAND-BASED PHARMACOPHORE STUDIES IN THE DOPAMINERGIC SYSTEM A thesis submitted in partial fulfilment of the requirements for the award of the degree DOCTOR OF PHILOSOPHY From UNIVERSITY OF WOLLONGONG By AMAR P. INAMDAR, B.PHARM., M.PHARM. SCHOOL OF CHEMISTRY November 2011 THESIS CERTIFICATION I, Amar P. Inamdar, declare that this thesis, submitted in partial fulfilment of the requirements for the award of Doctor of Philosophy, in the School of Chemistry, University of Wollongong, is wholly my own work unless otherwise referenced or acknowledged. The document has not been submitted for qualifications at any other academic institution. Amar P. Inamdar November 2011 i ACKNOWLEDGEMENTS I am truly grateful to my supervisor, Prof. John B. Bremner, whose support, encouragement and guidance has helped me immensely in the completion of this project. Most importantly, I am thankful for his patience over all these years and believing in me in spite of various difficult periods in this journey. I know he has sacrificed a significant amount of his personal time to make this happen. I also owe my deepest gratitude to Associate Prof.
    [Show full text]
  • Toxicological Profile for Chlorobenzene
    TOXICOLOGICAL PROFILE FOR CHLOROBENZENE Agency for Toxic Substances and Disease Registry U.S. Public Health Service December 1990 ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. 1 1. PUBLIC HEALTH STATEMENT This Statement was prepared to give you information about chlorobenzene and to emphasize the human health effects that may result from exposure to it. The Environmental Protection Agency (EPA) has identified 1,177 sites on its National Priorities List (NPL). Chlorobenzene has been found at 97 of these sites. However, we do not know how many of the 1,177 NPL sites have been evaluated for chlorobenzene. As EPA evaluates more sites, the number of sites at which chlorobenzene is found may change. The information is important for you because chlorobenzene may cause harmful health effects and because these sites are potential or actual sources of human exposure to chlorobenzene. When a chemical is released from a large area, such as an industrial plant, or from a container, such as a drum or bottle, it enters the environment as a chemical emission. This emission, which is also called a release, does not always lead to exposure. You can be exposed to a chemical only when you come into contact with the chemical. You may be exposed to it in the environment by breathing, eating, or drinking substances containing the chemical or from skin contact with it. If you are exposed to a hazardous substance such as chlorobenzene, several factors will determine whether harmful health effects will occur and what the type and severity of those health effects will be.
    [Show full text]
  • Kinetic Investigation of Nitroarylation of Pyrrole with 1-Chloro-4
    ienc Sc es al J c o i u m r e n a h l C Selvaraj et al., Chem Sci J 2015, 6:3 Chemical Sciences Journal DOI: 10.4172/2150-3494.1000104 ISSN: 2150-3494 Research Article Article OpenOpen Access Access Kinetic Investigation of Nitroarylation of Pyrrole with 1-Chloro-4- Nitrobenzene Using a New Multi-Site Phase-Transfer Catalyst under Ultrasonic Condition Selvaraj V1*, Harikumar K2, Sathiyaraj M3 and Rajendran V3 1PG Department of Chemistry, Sri Akilandeswari Women’s College, Wandiwash, Tamil Nadu, India 2Sri Chandrashekarendra Saraswathi Viswa Maha Vidyalaya University, Kanchipuram, Enathur, Tamil Nadu, India 3Department of Chemistry, Pachaiyappa’s College for Men, Kanchipuram, Tamil Nadu, India Abstract In the present research work, the solid-liquid reaction was successfully carried out in the new synthesized multi- site phase-transfer catalyst, namely i.e., 1,3,5-tribenzyl-1,3,5-triethyl-1,3,5-triazinane-1,3,5-triium trichloride(MPTC), and sonication (40 kHz, 300 W) to produce the desired product namely 1-(4-nitropheny) pyrrole from pyrrole and 4-nitrochlorobenzene. The selectivity of N-arylation product was obtained under sonication and MPTC. The combination of ultrasound and MPTC resulted in better efficacy as compared to the individual operations. The apparent reaction rate is greatly enhanced and observed to obey the pseudo-first order kinetics. The appk value increases with increasing kinetic parameters that is the amount of [MPTC], [substrate], ultrasonication, stirring speed, temperature, etc. Keywords: Sonochemistry; Pyrrole; Interfacial reaction; Kinetics; The effect of ultrasonic energies in organic syntheses (homogeneous MPTC; 1-Chloro-4-Nitrobenzene and heterogeneous reactions) has been boosted in recent years [21-27].
    [Show full text]
  • Chlorobenzenes (PDF)
    EPA-454/R-93-044 LOCATING AND ESTIMATING AIR EMISSIONS FROM SOURCES OF CHLOROBENZENES (REVISED) Office of Air Quality Planning and Standards U.S. Environmental Protection Agency Research Triangle Park, North Carolina 27711 March 1994 This report has been reviewed by the Office of Air Quality Planning and Standards, U.S. Environmental Protection Agency, and has been approved for publication. Any mention of trade names or commercial products is not intended to constitute endorsement or recommendation for use. ii CONTENTS Section Page DISCLAIMER ..................................................... ii LIST OF FIGURES .................................................. vi LIST OF TABLES .................................................. vii 1.0 PURPOSE OF DOCUMENT ..................................... 1-1 1.1 Reference for Section 1.0 ................................... 1-5 2.0 OVERVIEW OF DOCUMENT CONTENTS .......................... 2-1 2.1 References for Section 2.0 .................................. 2-5 3.0 BACKGROUND .............................................. 3-1 3.1 Nature of Pollutant ....................................... 3-1 3.1.1 Properties of Chlorobenzenes ........................... 3-5 3.1.2 Properties of Monochlorobenzene ........................ 3-6 3.1.3 Properties of Dichlorobenzenes .......................... 3-6 3.1.4 Properties of Trichlorobenzenes ......................... 3-7 3.1.5 Properties of Hexachlorobenzene ........................ 3-7 3.2 Overview of Production and Use .............................. 3-8 3.3
    [Show full text]